Etodolac and Compazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Compazine (prochlorperazine maleate). Common drug interactions include osteomyelitis among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Compazine. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

29 people who take Etodolac and Compazine together, and have interactions are studied.

Etodolac and Compazine drug interactions.

What are the common drug interactions of Etodolac and Compazine, by gender? *:

female:

  1. Osteomyelitis (infection of bone)
  2. Osteonecrosis of jaw (death of bone of jaw)
  3. Osteopenia (a condition where bone mineral density is lower than normal)
  4. Osteosclerosis (an elevation in bone density)
  5. Pelvic pain
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Synovitis (inflammation of the synovial membrane)
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Thyroid neoplasm (tumour of thyroid)
  10. Trigger finger

male:

  1. Dizziness
  2. Platelet count decreased
  3. Sleep disorder
  4. Visual impairment
  5. Anxiety
  6. Depression
  7. Gastric cancer (stomach cancer)
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Ataxia (loss of full control of bodily movements)
  10. Balance disorder

What are the common drug interactions of Etodolac and Compazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Ataxia (loss of full control of bodily movements)
  2. Back pain
  3. Blood glucose increased
  4. Blood potassium decreased
  5. Blood pressure increased
  6. Bone disorder
  7. Bone marrow disorder
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  10. Calcification metastatic (calcium overload in body tissue)

20-29:

n/a

30-39:

n/a

40-49:

  1. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  2. Cerebral atrophy (decrement in size of brain)
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Dizziness
  5. Intervertebral disc degeneration (spinal disc degeneration)
  6. Intervertebral disc protrusion (spinal disc protrusion)
  7. Neuropathy peripheral (surface nerve damage)
  8. Sleep disorder
  9. Visual impairment
  10. Anxiety

50-59:

  1. Chronic kidney disease
  2. Depression
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Renal failure (kidney dysfunction)

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Anxiety
  3. Peripheral nerve lesion
  4. Spinal column stenosis (narrowing of spinal column)
  5. Urinary tract infection
  6. Weight decreased
  7. Sleep disorder
  8. Aortic valve stenosis (narrowing of the aortic valve)
  9. Constipation
  10. Cushingoid (obesity and weakening of the muscles)

What are the existing conditions these people have? *

  1. Pain: 10 people, 34.48%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 31.03%
  3. Weight Decreased: 6 people, 20.69%
  4. Pain In Jaw: 6 people, 20.69%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.69%
  6. Muscle Spasms (muscle contraction): 6 people, 20.69%
  7. Headache (pain in head): 5 people, 17.24%
  8. Nausea (feeling of having an urge to vomit): 5 people, 17.24%
  9. Depression: 4 people, 13.79%
  10. High Blood Pressure: 4 people, 13.79%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Compazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Etodolac and Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etodolac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Etodolac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Compazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on etodolac and prochlorperazine maleate (the active ingredients of Etodolac and Compazine, respectively), and Etodolac and Compazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: